CRP and neoplasm: In-depth studies on the direct or indirect interaction between tumor cells and inflammatory factors, such as neutrophils, lymphocytes, monocytes, platelets, and C-reactive protein, have provided increasing evidence that the systemic inflammatory response affects patient prognosis by altering the tumor cell microenvironment (12–14).